Correction: Effects of statins on incident dementia in patients with type 2 DM: A population-based retrospective cohort study in Taiwan (PLoS ONE (2014) 9, 2 (e88434) DOI: 10.1371/journal.pone.0088434);Effects of statins on incident dementia in patients with type 2 DM: A population-based retrospective cohort study in Taiwan

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Chen, Jui Ming ^a,c,d   Chang, Cheng Wei ^b   Chang, Tzu Hao ^e   Hsu, Chi Chang ^f   Horng, Jorng Tzong ^d,f   Sheu, Wayne H H ^g,h,i,j  

^a TUNGS' TAICHUNG METROHARBOR HOSPITAL   (Taiwan)

^b HSING WU UNIVERSITY   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

^d NAN KAI UNIVERSITY OF TECHNOLOGY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^f NATIONAL CENTRAL UNIVERSITY   (Taiwan)

^g TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^h NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

ⁱ NATIONAL YANG MING UNIVERSITY   (Taiwan)

^j NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; ATORVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; MEGLITINIDE; METFORMIN; MEVINOLIN; PITAVASTATIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DEMENTIA; DIABETIC PATIENT; DISEASE ASSOCIATION; DRUG EFFECT; DRUG USE; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; RETROSPECTIVE STUDY; RISK REDUCTION; TAIWAN;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; DEMENTIA; DEMOGRAPHY; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TAIWAN;

EID: 84895515551     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100019     Document Type: Erratum

References (34)

1. Cukierman T, Gerstein HC, Williamson JD (2005) Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies. Diabetologia 48: 2460-2469. (Pubitemid 41738208)
2. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P (2006) Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 5: 64-74. (Pubitemid 41790697)
3. Wang KC, Woung LC, Tsai MT, Liu CC, Su YH, et al. (2012) Risk of Alzheimer's disease in relation to diabetes: a population-based cohort study. Neuroepidemiology 38: 237-244.
4. Ahtiluoto S, Polvikoski T, Peltonen M, Solomon A, Tuomilehto J, et al. (2010) Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study. Neurology 75: 1195-1202.
5. Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA (2004) Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 61: 661-666. (Pubitemid 38637681)
6. Janson J, Laedtke T, Parisi JE, O'Brien P, Petersen RC, et al. (2004) Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 53: 474-481. (Pubitemid 38174565)
7. Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA (2000) Statins and the risk of dementia. Lancet 356: 1627-1631.
8. Wolozin B, Kellman W, Ruosseau P, Celesia GG, Siegel G (2000) Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 57: 1439-1443.
9. Benito-Leon J, Louis ED, Vega S, Bermejo-Pareja F (2010) Statins and cognitive functioning in the elderly: a population-based study. J Alzheimers Dis 21: 95-102.
10. Trompet S, van Vliet P, de Craen AJ, Jolles J, Buckley BM, et al. (2010) Pravastatin and cognitive function in the elderly. Results of the PROSPER study. J Neurol 257: 85-90.
11. Ancelin ML, Carriere I, Barberger-Gateau P, Auriacombe S, Rouaud O, et al. (2012) Lipid lowering agents, cognitive decline, and dementia: the three-city study. J Alzheimers Dis 30: 629-637.
12. Wong WB, Lin VW, Boudreau D, Devine EB (2013) Statins in the prevention of dementia and Alzheimer's disease: a meta-analysis of observational studies and an assessment of confounding. Pharmacoepidemiol Drug Saf 22: 345-358.
13. Feldman HH, Doody RS, Kivipelto M, Sparks DL, Waters DD, et al. (2010) Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe. Neurology 74: 956-964.
14. NHIRD Introduction to the National Health Insurance Research Database (NHIRD), Taiwan.
15. Hsu CC, Wahlqvist ML, Lee MS, Tsai HN (2011) Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin. J Alzheimers Dis 24: 485-493.
16. Chang CW, Kok VC, Tseng TC, Horng JT, Liu CE (2012) Diabetic patients with severe sepsis admitted to intensive care unit do not fare worse than non-diabetic patients: a nationwide population-based cohort study. PLoS One 7: e50729.
17. Lin CH, Sheu WH (2013) Hypoglycaemic episodes and risk of dementia in diabetes mellitus: 7-year follow-up study. J Intern Med 273: 102-110.
18. Lin CC, Lai MS, Syu CY, Chang SC, Tseng FY (2005) Accuracy of diabetes diagnosis in health insurance claims data in Taiwan. J Formos Med Assoc 104: 157-163. (Pubitemid 44524953)
19. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40: 373-383. (Pubitemid 17055592)
20. Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45: 613-619.
21. Cramer C, Haan MN, Galea S, Langa KM, Kalbfleisch JD (2008) Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study. Neurology 71: 344-350.
22. Haag MD, Hofman A, Koudstaal PJ, Stricker BH, Breteler MM (2009) Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study. J Neurol Neurosurg Psychiatry 80: 13-17.
23. Yaffe K, Barrett-Connor E, Lin F, Grady D (2002) Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol 59: 378-384. (Pubitemid 34208144)
24. Fei M, Yan Ping Z, Ru Juan M, Ning Ning L, Lin G (2013) Risk factors for dementia with type 2 diabetes mellitus among elderly people in China. Age Ageing 42: 398-400.
25. Johnson ML, Parikh N, Kunik ME, Schulz PE, Patel JG, et al. (2012) Antihypertensive drug use and the risk of dementia in patients with diabetes mellitus. Alzheimers Dement 8: 437-444.
26. Li G, Larson EB, Sonnen JA, Shofer JB, Petrie EC, et al. (2007) Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease. Neurology 69: 878-885. (Pubitemid 47329587)
27. Rea TD, Breitner JC, Psaty BM, Fitzpatrick AL, Lopez OL, et al. (2005) Statin use and the risk of incident dementia: the Cardiovascular Health Study. Arch Neurol 62: 1047-1051. (Pubitemid 41043724)
28. International AsD (2009) World Alzheimer report.
29. Reitz C, Tang MX, Luchsinger J, Mayeux R (2004) Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch Neurol 61: 705-714. (Pubitemid 38637688)
30. Joshi HN, Fakes MG, Serajuddin ATM (1999) Differentiation of 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Inhibitors by Their Relative Lipophilicity. Pharmacy and Pharmacology Communications 5: 269-271. (Pubitemid 29245825)
31. Wolozin B, Wang SW, Li NC, Lee A, Lee TA, et al. (2007) Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease. BMC Med 5: 20.
32. Sparks DL, Sabbagh MN, Connor DJ, Lopez J, Launer LJ, et al. (2005) Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results. Arch Neurol 62: 753-757. (Pubitemid 40656090)
33. Heart Protection Study Collaborative Group (2002) MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360: 7-22.
34. Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, et al. (2002) Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 360: 1623-1630. (Pubitemid 35379733)